# Chemed Corp: Form 10-K for the period ended Dec 31, 2011

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-K
- Filed: 2012-02-27
- Accepted by EDGAR: Feb 27, 2012, 15:35 ET
- Period: 2011-12-31
- Accession: 0001157523-12-001051
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752312001051/a50173390.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752312001051/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2011-01-01 to 2011-12-31 | $1.36bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months, 2011-01-01 to 2011-12-31 | $970.5m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 12 months, 2011-01-01 to 2011-12-31 | $202.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2011-01-01 to 2011-12-31 | $153.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2011-01-01 to 2011-12-31 | $13.9m | us-gaap:InterestExpense |
| Income tax | 12 months, 2011-01-01 to 2011-12-31 | $54.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2011-01-01 to 2011-12-31 | $86.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2011-01-01 to 2011-12-31 | $4.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2011-01-01 to 2011-12-31 | $4.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2011-01-01 to 2011-12-31 | 20,945,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2011-01-01 to 2011-12-31 | $174.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2011-01-01 to 2011-12-31 | $29.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2011-01-01 to 2011-12-31 | $12.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2011-01-01 to 2011-12-31 | $144.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-12-31 | $38.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-12-31 | $150.8m | us-gaap:AssetsCurrent |
| Total assets | at 2011-12-31 | $795.9m | us-gaap:Assets |
| Current liabilities | at 2011-12-31 | $145.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-12-31 | $382.2m | us-gaap:Liabilities |
| Long-term debt | at 2011-12-31 | $166.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2011-12-31 | $413.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752312001051/a50173390.htm

Filed Feb 27, 2012.
Source: SEC EDGAR, the filing index for accession 0001157523-12-001051. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
